Mirjana Doknić

1.8k total citations
72 papers, 1.3k citations indexed

About

Mirjana Doknić is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Endocrine and Autonomic Systems. According to data from OpenAlex, Mirjana Doknić has authored 72 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Surgery and 10 papers in Endocrine and Autonomic Systems. Recurrent topics in Mirjana Doknić's work include Pituitary Gland Disorders and Treatments (37 papers), Growth Hormone and Insulin-like Growth Factors (32 papers) and Adrenal and Paraganglionic Tumors (13 papers). Mirjana Doknić is often cited by papers focused on Pituitary Gland Disorders and Treatments (37 papers), Growth Hormone and Insulin-like Growth Factors (32 papers) and Adrenal and Paraganglionic Tumors (13 papers). Mirjana Doknić collaborates with scholars based in Serbia, Poland and Czechia. Mirjana Doknić's co-authors include Vera Popović, Sandra Pekić, Dragana Miljić, Marina Djurovic, Felipe F. Casanueva, Djuro Μacut, Jelica Bjekić-Macut, Dario Rahelić, Carlos Diéguez and Nataša Milić and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and International Journal of Molecular Sciences.

In The Last Decade

Mirjana Doknić

63 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mirjana Doknić Serbia	19	523	246	204	200	163	72	1.3k
Sandra Pekić Serbia	21	862 1.6×	296 1.2×	93 0.5×	263 1.3×	261 1.6×	89	1.9k
Svetozar Damjanović Serbia	23	865 1.7×	393 1.6×	251 1.2×	266 1.3×	200 1.2×	105	1.7k
Dragana Miljić Serbia	17	439 0.8×	350 1.4×	61 0.3×	239 1.2×	144 0.9×	63	1.1k
Elena Valassi Spain	26	1.9k 3.6×	378 1.5×	184 0.9×	368 1.8×	231 1.4×	85	2.8k
A. Grossman United Kingdom	25	710 1.4×	273 1.1×	108 0.5×	224 1.1×	329 2.0×	47	1.8k
Nasim C. Sobhani United States	9	137 0.3×	263 1.1×	119 0.6×	194 1.0×	118 0.7×	38	838
Kazuhiko Horiguchi Japan	18	638 1.2×	613 2.5×	84 0.4×	345 1.7×	224 1.4×	59	1.7k
Marina Djurovic Czechia	16	590 1.1×	406 1.7×	36 0.2×	243 1.2×	130 0.8×	42	1.1k
L. H. Rees United Kingdom	26	769 1.5×	130 0.5×	315 1.5×	174 0.9×	346 2.1×	59	2.0k
Zila Shen‐Orr Israel	22	866 1.7×	375 1.5×	126 0.6×	322 1.6×	435 2.7×	32	1.8k

Countries citing papers authored by Mirjana Doknić

Since Specialization

Citations

This map shows the geographic impact of Mirjana Doknić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirjana Doknić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirjana Doknić more than expected).

Fields of papers citing papers by Mirjana Doknić

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirjana Doknić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirjana Doknić. The network helps show where Mirjana Doknić may publish in the future.

Co-authorship network of co-authors of Mirjana Doknić

This figure shows the co-authorship network connecting the top 25 collaborators of Mirjana Doknić. A scholar is included among the top collaborators of Mirjana Doknić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirjana Doknić. Mirjana Doknić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Biller, Beverly M. K., Christian J. Strasburger, Martin Bidlingmaier, et al.. (2025). OR12-07 Disease Control in Patients With Acromegaly Switching From Injected Somatostatin Receptor Ligands to Once-Daily Oral Paltusotine: Interim Results of the PATHFNDR-1 Open-Label Extension. Journal of the Endocrine Society. 9(Supplement_1).

Doknić, Mirjana, Marko Stojanović, Dragana Miljić, & M Milićević. (2024). Medical treatment of acromegaly – When the tumor size matters: A narrative review. Growth Hormone & IGF Research. 78. 101608–101608. 2 indexed citations

Biller, Beverly M. K., Aleksandra Gilis‐Januszewska, Mirjana Doknić, et al.. (2024). 12542 Results Of The Foresight Trial Support The Efficacy And Safety Of Once-weekly Lonapegsomatropin In Adults With Growth Hormone Deficiency (ghd). Journal of the Endocrine Society. 8(Supplement_1).

Ferone, Diego, Joanna L. Spencer-Segal, Güzin Fidan Yaylalı, et al.. (2024). 7376 Efficacy and Safety of CAM2029 in Patients With Controlled or Inadequately Controlled Acromegaly on Standard-of-Care Treatment: Interim Data for the “New to CAM2029” Patient Subgroup in a Phase 3 Study (ACROINNOVA 2). Journal of the Endocrine Society. 8(Supplement_1).

Gadelha, Mônica R., Christian J. Strasburger, Martin Bidlingmaier, et al.. (2024). Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine. The Journal of Clinical Endocrinology & Metabolism. 110(1). 228–237. 12 indexed citations

Doknić, Mirjana, et al.. (2024). Transition Period and Young Adulthood in Patients with Childhood Onset Growth Hormone Deficiency (COGHD): Impact of Growth Hormone Replacement on Bone Mass and Body Composition. International Journal of Molecular Sciences. 25(19). 10313–10313. 1 indexed citations

Gadelha, Mônica R., Harpal Randeva, Murray B. Gordon, et al.. (2023). OR01-01 Oral, Once-daily, Paltusotine (Non-peptide Selective Somatostatin Receptor Subtype 2 Agonist) Therapy In Patients With Acromegaly Is Associated With Long-term Biochemical And Symptom Control And Is Preferred Over Injectable Somatostatin-Receptor Ligands. Journal of the Endocrine Society. 7(Supplement_1). 3 indexed citations

Gadelha, Mônica R., Murray B. Gordon, Mirjana Doknić, et al.. (2022). ACROBAT Edge: Safety and Efficacy of Switching Injected SRLs to Oral Paltusotine in Patients With Acromegaly. The Journal of Clinical Endocrinology & Metabolism. 108(5). e148–e159. 19 indexed citations

Shimon, Ilan, Corin Badiu, Artur Bossowski, et al.. (2019). Adult growth hormone deficiency in CEE region: Heterogeneity of the patient pathway. Growth Hormone & IGF Research. 46-47. 44–49. 6 indexed citations

10.

Doknić, Mirjana, Dragana Miljić, Sandra Pekić, et al.. (2018). Single center study of 53 consecutive patients with pituitary stalk lesions. Pituitary. 21(6). 605–614. 6 indexed citations

11.

Miljić, Dragana, Mirjana Doknić, Marko Stojanović, et al.. (2017). Impact of etiology, age and gender on onset and severity of hyponatremia in patients with hypopituitarism: retrospective analysis in a specialised endocrine unit. Endocrine. 58(2). 312–319. 13 indexed citations

12.

Petronijević, Nataša, Jelena Sopta, Mirjana Doknić, et al.. (2013). Chronic risperidone exposure does not show any evidence of bone mass deterioration in animal model of schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 46. 58–63. 6 indexed citations

13.

Miljić, Dragana, Aleksandar Ljubić, Michael Patterson, et al.. (2010). Kisspeptin levels in high risk pregnancies related to chronic diseases: insulin dependent diabetes mellitus (IDDM) and arterial hypertension (H). 1 indexed citations

14.

Miljić, Dragana, Mirjana Doknić, Miomira Ivović, et al.. (2010). ACTH and Cortisol responses to ghrelin and desmopressin in patients with Cushing’s disease and adrenal enlargement. Journal of Endocrinological Investigation. 33(8). 526–529. 5 indexed citations

15.

Pekić, Sandra, Vladimir Jovanović, Marko Stojanović, et al.. (2009). Screening for neuroendocrine dysfunction in patients after spontaneous subarachnoid hemorrhage. 1 indexed citations

16.

Stojanović, Marko, Sandra Pekić, Dragan Pavlović, et al.. (2008). The effects of growth hormone deficiency following moderate and severe traumatic brain injury on cognitive functions. 12(11). 1 indexed citations

17.

Popović, Vera, Mirjana Doknić, Nadja P. Marić, et al.. (2007). Changes in Neuroendocrine and Metabolic Hormones Induced by Atypical Antipsychotics in Normal-Weight Patients with Schizophrenia. Neuroendocrinology. 85(4). 249–256. 54 indexed citations

18.

Popovic, V., Marina Djurovic, Mirjana Doknić, et al.. (2004). Circulating and cerebrospinal fluid ghrelin and leptin: potential role in altered body weight in Huntington's disease. European Journal of Endocrinology. 151(4). 451–455. 91 indexed citations

19.

Pekić, Sandra, Svetozar Damjanović, Marina Djurovic, et al.. (2004). Retroperitoneal Malignant Fibrous Histiocytoma Mimicking Pheochromocytoma. Endocrine. 24(1). 99–104. 4 indexed citations

20.

Damjanović, Svetozar, et al.. (1996). Gonadotrophin and free α-subunit secretion in patients with acromegaly and clinically non-functioning pituitary tumors: Anterior pituitary function and the effect of thyrotrophin-releasing hormone. Journal of Endocrinological Investigation. 19(10). 663–669. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact